arrow
L

Laura Zanotti

Angelo Nocivelli Institute of Molecular Medicine
H指数:34
被引数:3,695

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Decoding BRCA1 and BRCA2 mutations in high-grade serous ovarian cancer: impact of location and type of mutation on prognosis and PARP inhibitor treatment

解码高级别浆液性卵巢癌中的BRCA1和BRCA2突变:突变位置和类型对预后及PARP抑制剂治疗的影响

2026-04-030
PRE
Integrated mutational landscape analysis of uterine leiomyosarcomas
2021-04-0568
OA
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients

Claudin-7低表达可作为高级别浆液性卵巢癌患者远处转移的潜在预测因子

2020-08-048
OAAI
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer

PRKG1,SDF2L1和PPP1R12A的表达谱是高级别浆液性卵巢癌治疗反应和生存的预测和预后因素

2020-03-1316
OAAI
Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy
2019-10-1756
OAAI
Altered adipocyte differentiation and unbalanced autophagy in type 2 Familial Partial Lipodystrophy: an in vitro and in vivo study of adipose tissue browning
2019-08-0231
OAAI
Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors
2018-12-2456
OAAI
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis
2017-05-2514
OAAI